Metronidazole Benzoate Oral Suspension from Canada
Pediatric metronidazole benzoate oral suspension (200mg/5ml) treats protozoal infections in children. HTS 3004.90.92.09 covers this salt form in measured doses for prophylactic and therapeutic retail use.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include pediatric exclusivity data and shake-well labeling compliance
• Validate beyond-use dating for reconstituted suspensions
• Test for preservative efficacy per USP <51> before import clearance